The Canadian multicenter, randomized, double-blind trial of the sirolimus-eluting stent in the treatment of patients with de novo coronary artery lesions (C-SIRIUS): 365 day complete clinical follow-up

被引：0
|
作者：
Schampaert, E [1 ]
机构：
[1] Hop Sacre Coeur Montreal, Montreal, PQ, Canada
来源：
CIRCULATION | 2003年 / 108卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3193
引用
收藏
页码：703 / 704
页数：2
相关论文
共 50 条
  • [41] A randomized trial of the endeavor drug (ABT-578) eluting stent system versus the cypher sirolimus-eluting coronary stent system in De Novo native coronary artery lesions: Thirty-day results
    Kandzari, DE
    O'Shaughnessy, C
    Ball, M
    Turco, M
    Midei, M
    Applegate, R
    Kuntz, RE
    Fitzgerald, P
    Milstein, A
    Popma, JJ
    Leon, MB
    CIRCULATION, 2004, 110 (17) : 564 - 564
  • [42] The fate of patients with clinical recurrence after sirolimus-eluting stent implantation (a two-year follow-up analysis from the SIRIUS trial)
    Moussa, ID
    Moses, JW
    Kuntz, RE
    Holmes, DR
    Popma, JJ
    Teirstein, PS
    Wong, SC
    Leon, MB
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (11): : 1582 - 1584
  • [43] Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)
    Kandzari, David E.
    Mauri, Laura
    Popma, Jeffrey J.
    Turco, Mark A.
    Gurbel, Paul A.
    Fitzgerald, Peter J.
    Leon, Martin B.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (05) : 543 - 550
  • [44] A randomized trial of the endeavor drug (ABT-578) eluting stent system versus the cypher sirolimus-eluting coronary Stent system in de novo native coronary artery lesions: ENDEAVOR III
    Kandzari, DE
    O'Shaunessy, C
    Ball, M
    Turco, M
    Kuntz, RE
    Fitzgerald, P
    Popma, JJ
    Leon, MB
    CIRCULATION, 2005, 112 (17) : U611 - U611
  • [45] Four-Year Clinical Follow-Up of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With De Novo Coronary Artery Lesions: The SPIRIT II Trial
    Garg, Scot
    Serruys, Patrick W.
    Miquel-Hebert, Karine
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2011, 77 (07) : 1012 - 1017
  • [46] Three-year clinical follow-up of the firehawk abluminal groove-filled biodegradable polymer sirolimus-eluting stent in the treatment of single de novo native coronary lesions: the TARGET 1 trial
    Xu, Bo
    Zhao, Yelin
    Yang, Yuejin
    Leon, Martin
    Guan, Changdong
    CARDIOLOGY, 2014, 129 : 71 - 72
  • [47] Three-Year Clinical Follow-Up of the FIREHAWK Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent in the Treatment of Single De Novo Native Coronary Lesions: The TARGET I Trial
    Xu, Bo
    Zhao, Yelin
    Yang, Yuejin
    Changsheng, Ma
    Han, Yaling
    Chen, Shao Liang
    Li, Hui
    Zhang, Ruiyan
    Leon, Martin
    Gao, Run-Lin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B172 - B172
  • [48] Nine-month angiographic and two-year clinical follow-up of polymer-free sirolimus-eluting stent versus durable-polymer sirolimus-eluting stent for coronary artery disease: the Nano randomized trial
    Zhang Yaojun
    Chen Fang
    Muramatsu, Takashi
    Xu Bo
    Li Zhanquan
    Ge Junbo
    He Qing
    Yang Zhijian
    Li Shumei
    Wang Lefeng
    Wang Haichang
    He Ben
    Li Kang
    Qi Guoxian
    Li Tianchang
    Zeng Hesong
    Peng Jianjun
    Jiang Tieming
    Zeng Qiutang
    Zhu Jianhua
    Fu Guosheng
    Bourantas, Christos V.
    Serruys, Patrick W.
    Huo Yong
    CHINESE MEDICAL JOURNAL, 2014, 127 (11) : 2153 - 2158
  • [49] Everolimus-eluting Stent for the treatment of de novo coronary lesions: B-angiographic follow-up of the FUTURE trial
    Costa, RA
    Lansky, AJ
    Mehran, R
    Tsuchiya, Y
    Cristea, E
    Negoita, M
    Aymong, E
    Pop, R
    Gilutz, Y
    Nikolsky, E
    Leon, MB
    Grube, E
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (6A): : 61L - 61L
  • [50] Five-year results of the Multicenter Randomized Controlled Open-Label Study of the CYPHER Sirolimus-Eluting Stent in the Treatment of Diabetic Patients with De Novo Native Coronary Artery Lesions (SCORPIUS) study: A German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients
    Sinning, Jan-Malte
    Baumgart, Dietrich
    Werner, Nikos
    Klauss, Volker
    Baer, Frank M.
    Hartmann, Franz
    Drexler, Helmut
    Motz, Wolfgang
    Klues, Heinrich
    Voelker, Wolfram
    Pfannebecker, Thomas
    Stoll, Hans-Peter
    Nickenig, Georg
    AMERICAN HEART JOURNAL, 2012, 163 (03) : 446 - U397
12345